ACC
ABBV icon

Acorn Creek Capital’s AbbVie ABBV Stock Holding History

Acorn Creek Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
2,237
-94
-4% -$20.2K 0.19% 34
2026
Q1 		$507K Sell
2,331
-20
-0.9% -$4.44K 0.18% 35
2025
Q4 		$537K Buy
2,351
+13
+0.6% +$2.96K 0.19% 31
2025
Q3 		$541K Buy
2,338
+171
+8% +$34.8K 0.2% 32
2025
Q2 		$402K Sell
2,167
-51
-2% -$9.48K 0.17% 37
2025
Q1 		$465K Sell
2,218
-71
-3% -$13.8K 0.23% 33
2024
Q4 		$407K Sell
2,289
-53
-2% -$9.74K 0.21% 37
2024
Q3 		$463K Buy
2,342
+65
+3% +$12.1K 0.25% 34
2024
Q2 		$391K Sell
2,277
-44
-2% -$7.29K 0.23% 37
2024
Q1 		$423K Buy
2,321
+199
+9% +$34.3K 0.27% 35
2023
Q4 		$329K Buy
+2,122
New +$309K 0.15% 47

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Acorn Creek Capital's ABBV Position: Q2 2026 in Review

Acorn Creek Capital reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $20.2K and leaving 2,237 shares worth $563K. The position accounts for 0.19% of the portfolio, ranked #34.

Acorn Creek Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Acorn Creek Capital held 2,237 shares of AbbVie worth $563K as of Q2 2026.
  • Acorn Creek Capital sold 94 AbbVie shares in Q2 2026, an estimated $20.2K.
  • AbbVie made up 0.19% of Acorn Creek Capital's portfolio in Q2 2026, its #34 holding.
  • Acorn Creek Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Acorn Creek Capital's 13F filing for Q2 2026, filed 6 Aug 2026.